Clinical trial
Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On…
NCT00407797 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Terminated
Key facts
| NCT number | NCT00407797 |
|---|---|
| Title | Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial |
| Official title | Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial. A Phase IV Open-Label Trial Using 150,300, 600 mg/Day Of Pregabalin |
| Acronym | PREPS MEXICO |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Partial Seizures |
| Intervention type | Drug |
| Interventions | Pregabalin |
| Enrollment | 136 |
| Start date | Mar 1, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Dec 5, 2006 |
| Last update posted | Jan 25, 2021 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: